de Zeeuw D - Search Results

1

Dose of doxorubicin determines severity of renal damage and responsiveness to ACE-inhibition in experimental nephrosis.

Wapstra FH, van Goor H, de Jong PE, Navis G, de Zeeuw D. Wapstra FH, et al. Among authors: de jong pe, de zeeuw d. J Pharmacol Toxicol Methods. 1999 Apr-Jun;41(2-3):69-73. doi: 10.1016/s1056-8719(99)00015-5. J Pharmacol Toxicol Methods. 1999. PMID: 10598677

2

Angiotensin II does not acutely reverse the reduction of proteinuria by long-term ACE inhibition.

Heeg JE, de Jong PE, van der Hem GK, de Zeeuw D. Heeg JE, et al. Among authors: de jong pe, de zeeuw d. Kidney Int. 1991 Oct;40(4):734-41. doi: 10.1038/ki.1991.268. Kidney Int. 1991. PMID: 1660550 Free article. Clinical Trial.

3

Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril.

Heeg JE, de Jong PE, van der Hem GK, de Zeeuw D. Heeg JE, et al. Among authors: de jong pe, de zeeuw d. Kidney Int. 1989 Aug;36(2):272-9. doi: 10.1038/ki.1989.190. Kidney Int. 1989. PMID: 2550696 Free article. Clinical Trial.

4

Additive antiproteinuric effect of ACE inhibition and a low-protein diet in human renal disease.

Gansevoort RT, de Zeeuw D, de Jong PE. Gansevoort RT, et al. Among authors: de jong pe, de zeeuw d. Nephrol Dial Transplant. 1995;10(4):497-504. doi: 10.1093/ndt/10.4.497. Nephrol Dial Transplant. 1995. PMID: 7623991 Clinical Trial.

5

Is the antiproteinuric effect of ACE inhibition mediated by interference in the renin-angiotensin system?

Gansevoort RT, de Zeeuw D, de Jong PE. Gansevoort RT, et al. Among authors: de jong pe, de zeeuw d. Kidney Int. 1994 Mar;45(3):861-7. doi: 10.1038/ki.1994.113. Kidney Int. 1994. PMID: 8196289 Free article. Clinical Trial.

6

Long-term benefits of the antiproteinuric effect of angiotensin-converting enzyme inhibition in nondiabetic renal disease.

Gansevoort RT, de Zeeuw D, de Jong PE. Gansevoort RT, et al. Among authors: de jong pe, de zeeuw d. Am J Kidney Dis. 1993 Jul;22(1):202-6. doi: 10.1016/s0272-6386(12)70187-7. Am J Kidney Dis. 1993. PMID: 8322784

7

Antiproteinuric effect predicts renal protection by angiotensin-converting enzyme inhibition in rats with established adriamycin nephrosis.

Wapstra FH, Van Goor H, Navis G, De Jong PE, De Zeeuw D. Wapstra FH, et al. Among authors: de jong pe, de zeeuw d. Clin Sci (Lond). 1996 May;90(5):393-401. doi: 10.1042/cs0900393. Clin Sci (Lond). 1996. PMID: 8665777

8

ACE inhibitors and the kidney. A risk-benefit assessment.

Navis G, Faber HJ, de Zeeuw D, de Jong PE. Navis G, et al. Among authors: de jong pe, de zeeuw d. Drug Saf. 1996 Sep;15(3):200-11. doi: 10.2165/00002018-199615030-00005. Drug Saf. 1996. PMID: 8879974 Review.

9

Prognostic value of the short-term antiproteinuric response to ACE inhibition for prediction of GFR decline in patients with nondiabetic renal disease.

Wapstra FH, Navis G, de Jong PE, de Zeeuw D. Wapstra FH, et al. Among authors: de jong pe, de zeeuw d. Exp Nephrol. 1996;4 Suppl 1:47-52. Exp Nephrol. 1996. PMID: 9001897 Review.

10

Titrating for antiproteinuric effect: the clue to renoprotection?

Navis G, de Zeeuw D. Navis G, et al. Among authors: de zeeuw d. J Hum Hypertens. 1996 Oct;10(10):669-73. J Hum Hypertens. 1996. PMID: 9004092 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

659 results

Search Page

Filters